Trial Profile
A Study to Evaluate the Efficacy and Safety of Combination of S-1 and Nedaplatin in Patients with Oral Squamous Cell Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Nedaplatin (Primary)
- Indications Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Dec 2015 New trial record